Refine my results
Document type
Institution
Specific Collection
Language
- English (2)
Author
-
Napoli, N. (2)
- Rizzoli, R. (2)
- Body, J.-J (1)
- Bouxsein, M. (1)
- Brandi, M.-L (1)
- Cannata-Andia, J. (1)
- Chappard, D. (1)
- Cooper, C. (1)
- El Hajj Fuleihan, G. (1)
- El Maghraoui, A. (1)
- Glüer, C. (1)
- Kanis, J. (1)
- Kendler, D. (1)
- Papaioannou, A. (1)
- Papapoulos, S. (1)
- Pierroz, D. (1)
- Rahme, M. (1)
- Reginster, J.-Y (1)
- Van Poznak, C. (1)
- de Villiers, T. (1)
- Åkesson, K. (1) More Less
Keyword
- ABCSG : Austrian Breast & Colorectal Cancer Study Group (1)
- ADT : Androgen deprivation therapy (1)
- AI : Aromatase inhibitor (1)
- ALP : Alkaline phosphatase (1)
- ASCO : American Society of Clinical Oncology (1)
- ATAC : Arimidex, Tamoxifen Alone or in Combination (1)
- AZURE : Adjuvant Zoledronic Acid to Reduce Recurrence (1)
- Atypical (1)
- BMD : Bone mineral density (1)
- BTM : Bone turnover marker (1)
- Bisphosphonate (1)
- Bone (1)
- CI : Confidence interval (1)
- CMF : Cyclophosphamide-methotrexate-5 fluorouracil (1)
- CT : Computed tomography (1)
- CTX : Cross-linked terminal telopeptide (1)
- Cancer (1)
- DKK1 : Dickkopf-related protein (1)
- DXA : Dual-energy X-ray absorptiometry (1)
- ER : Estrogen receptor (1)
- ESCEO : European Society for Clinical and Economical Aspects of Osteoporosis and Osteoarthritis (1)
- ET : Endothelin (1)
- FAC : 5-Fluorouracil-doxorubicin-cyclophosphamide (1)
- FDG : Fluorodeoxyglucose (1)
- FGF : Fibroblast growth factor (1)
- FRAX : WHO fracture risk assessment tool (1)
- Femur (1)
- GnRH : Gonadotropin-releasing hormone (1)
- HR : Hazard ratio (1)
- IES : Intergroup Exemestane Study (1) More Less